Shell Asset Management CO Biomarin Pharmaceutical Inc Transaction History

Shell Asset Management CO

$2.2 Billion
Q1 2024

A detailed history of Shell Asset Management CO transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Shell Asset Management CO holds 2,515 shares of BMRN stock, worth $176,779. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,515

Previous 2,515 -0.0%

Holding current value

$176,779

Previous $220,000 5.91%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $12,152 - $14,355	-145 Reduced 5.45%	2,515 $220,000
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $90,473 - $116,931	-1,187 Reduced 30.86%	2,660 $256,000
Q3 2023 Nov 08, 2023	BUY	$85.07 - $94.48 $29,859 - $33,162	351 Added 10.04%	3,847 $340,000
Q2 2023 Jul 28, 2023	SELL	$86.68 - $100.3 $657,641 - $760,976	-7,587 Reduced 68.46%	3,496 $303,000
Q4 2022 Feb 07, 2023	SELL	$80.93 - $108.63 $153,200 - $205,636	-1,893 Reduced 14.59%	11,083 $1.15 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $281,644 - $332,310	-3,428 Reduced 20.9%	12,976 $1.1 Million
Q2 2022 Aug 09, 2022	SELL	$71.48 - $86.85 $123,088 - $149,555	-1,722 Reduced 9.5%	16,404 $1.36 Million
Q1 2022 May 04, 2022	SELL	$74.28 - $92.69 $38,179 - $47,642	-514 Reduced 2.76%	18,126 $1.4 Million
Q4 2021 Feb 09, 2022	BUY	$71.72 - $91.47 $156,923 - $200,136	2,188 Added 13.3%	18,640 $1.65 Million
Q3 2021 Nov 04, 2021	SELL	$74.77 - $85.47 $1.03 Million - $1.18 Million	-13,784 Reduced 45.59%	16,452 $1.27 Million
Q2 2021 Aug 12, 2021	BUY	$75.51 - $84.79 $1.27 Million - $1.43 Million	16,885 Added 126.47%	30,236 $2.52 Million
Q1 2021 May 10, 2021	SELL	$74.73 - $90.69 $1.28 Million - $1.55 Million	-17,129 Reduced 56.2%	13,351 $1.01 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $1.56 Million - $1.94 Million	21,473 Added 238.4%	30,480 $2.67 Million
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $16,314 - $29,743	-227 Reduced 2.46%	9,007 $685,000
Q2 2020 Aug 10, 2020	SELL	$79.55 - $124.22 $976,078 - $1.52 Million	-12,270 Reduced 57.06%	9,234 $1.14 Million
Q1 2020 May 11, 2020	SELL	$71.37 - $96.85 $35,685 - $48,425	-500 Reduced 2.27%	21,504 $1.82 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $301,747 - $405,507	4,695 Added 27.12%	22,004 $1.86 Million
Q2 2019 Aug 12, 2019	SELL	$80.35 - $93.9 $112,489 - $131,460	-1,400 Reduced 7.48%	17,309 $1.48 Million
Q1 2019 May 09, 2019	BUY	$84.2 - $98.62 $213,110 - $249,607	2,531 Added 15.64%	18,709 $1.66 Million
Q4 2018 Feb 13, 2019	SELL	$80.14 - $106.07 $525,558 - $695,607	-6,558 Reduced 28.84%	16,178 $1.38 Million
Q3 2018 Nov 13, 2018	SELL	$93.92 - $105.72 $58,418 - $65,757	-622 Reduced 2.66%	22,736 $2.21 Million
Q2 2018 Aug 10, 2018	BUY	$76.01 - $99.03 $49,634 - $64,666	653 Added 2.88%	23,358 $2.2 Million
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $4,038 - $4,816	-52 Reduced 0.23%	22,705 $1.84 Million
Q4 2017 Feb 09, 2018	BUY	$80.76 - $95.13 $245,671 - $289,385	3,042 Added 15.43%	22,757 $2.03 Million
Q3 2017 Oct 20, 2017	SELL	$80.6 - $94.95 $735,878 - $866,893	-9,130 Reduced 31.65%	19,715 $1.84 Million
Q3 2017 Oct 18, 2017	BUY	$80.6 - $94.95 $2.32 Million - $2.74 Million	28,845	28,845 $2.08 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Biomarin Pharmaceutical Inc Transaction History